ALPHAMAB ONCOLO.DL-000002 (3NK) — Working Capital to Net Assets Ratio
ALPHAMAB ONCOLO.DL-000002 (3NK) has a Working Capital to Net Assets ratio of 76.7% as of December 2025. Working capital of €1.31 Billion (current assets of €1.59 Billion minus current liabilities of €280.85 Million) is measured against net assets of €1.71 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is ALPHAMAB ONCOLO.DL-000002's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ALPHAMAB ONCOLO.DL-000002 Working Capital to Net Assets (2021–2025)
This chart shows how ALPHAMAB ONCOLO.DL-000002's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 76.7%, reflecting working capital of €1.31 Billion against net assets of €1.71 Billion EUR. Check tangible net worth ratio of ALPHAMAB ONCOLO.DL-000002 to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for ALPHAMAB ONCOLO.DL-000002 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for ALPHAMAB ONCOLO.DL-000002 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is ALPHAMAB ONCOLO.DL-000002 worth.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 76.7% | €1.31 Billion | €1.71 Billion | €1.59 Billion | €280.85 Million | ▼ -2.8 pp |
| 2024 | 79.6% | €1.46 Billion | €1.83 Billion | €1.71 Billion | €254.04 Million | ▲ +2.3 pp |
| 2023 | 77.2% | €1.29 Billion | €1.67 Billion | €1.56 Billion | €266.84 Million | ▲ +6.0 pp |
| 2022 | 71.2% | €1.11 Billion | €1.56 Billion | €1.49 Billion | €384.91 Million | ▼ -7.9 pp |
| 2021 | 79.1% | €1.48 Billion | €1.87 Billion | €2.12 Billion | €637.26 Million | — |